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Abstract
Background: It has become an accepted procedure to transfer more than one embryo to the
patient to achieve acceptable ongoing pregnancy rates. However, transfers of more than a single
embryo increase the probability of establishing a multiple gestation. Single-embryo transfer can
minimize twin pregnancies but may also lower live birth rates. This meta-analysis aimed to compare
current data on single-embryo versus double-embryo transfer in fresh IVF/ICSI cycles with respect
to implantation, ongoing pregnancy and live birth rates.
Methods:  Search strategies included on-line surveys of databases from 1995 to 2008. Data
management and analysis were conducted using the Stats Direct statistical software. The fixed-
effect model was used for odds ratio (OR). Fixed-effect effectiveness was evaluated by the Mantel
Haenszel method. Seven trials fulfilled the inclusion criteria.
Results:  When pooling results under the fixed-effect model, the implantation rate was not
significantly different between double-embryo transfer (34.5%) and single-embryo transfer group
(34.7%) (P = 0.96; OR = 0.99, 95% CI 0.78, 1.25). On the other hand, double-embryo transfer
produced a statistically significantly higher ongoing clinical pregnancy rate (44.5%) than single-
embryo transfer (28.3%) (P < 0.0001; OR:2.06, 95% CI = 1.64,2.60). At the same time, pooling
results presented a significantly higher live birth rate when double-embryo transfer (42.5%) (P <
0.001; OR: 1.87, 95% CI = 1.44,2.42) was compared with single-embryo transfer (28.4%).
Conclusion: Meta-analysis with 95% confidence showed that, despite similar implantation rates,
fresh double-embryo transfer had a 1.64 to 2.60 times greater ongoing pregnancy rate and 1.44 to
2.42 times greater live birth rate than single-embryo transfer in a population suitable for ART
treatment.
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Background
Historically, embryos have been replaced in the uterus on
either day 2 or 3 of development with resultant implanta-
tion rates of between 10% and 30% [1]. As a direct conse-
quence of these low implantation rates, it has become an
accepted procedure to transfer more than one embryo to
the patient to achieve acceptable ongoing pregnancy rates.
Thus, the transfer of more than a single embryo results in
the finite probability of establishing a multiple gestation.
However, global efforts have been directed toward reduc-
tion of multiple gestations. Initiated by European
researchers, this notion has resulted in the concept of elec-
tive single-embryo transfer (SET), which has achieved
high popularity. Traditional arguments in favor of trans-
ferring a low number of embryos are based on the strongly
augmented maternal and perinatal risks of multifetal
pregnancy, increased social and political pressure and a
decreased need for multifetal pregnancy reduction [2]. At
the European Society of Human Reproduction and
Embryology (ESHRE) consensus meeting in 2002, it was
agreed that the preferred ART outcome should be the birth
of one child and that a twin pregnancy should be consid-
ered a complication [3]. Nevertheless, the growth of SET is
still very modest in Europe (12% in 2001 versus 13.5% in
2002, 15.7% in 2003 and 19.1% in 2004) [4]. Twin deliv-
eries after IVF/ICSI are still close to 22% (2004) in Europe
[4].
On the other hand, the Guidelines established by the
ASRM and SART [5] recommend a limit of 1–2 cleavage-
stage embryos for transfer even in favorable patients
younger than 35 years. According to these Guidelines and
depending on the woman's age and prognosis, the recom-
mended number of embryos to transfer ranges between 2
and 5 (or even more "depending on individual circum-
stances after appropriate consultation"). Thus, in the USA
the rate of SET is expressively lower than in Europe and
presents low growth (6.2% in 2001 versus 6.7% in 2002,
7.5% in 2003, 8.2% in 2004 and 9.3% in 2005) [6]. In
fact, shifting from high order embryo transfer (3 or more
embryos) to double-embryo transfer (DET) apparently
does not interfere in the results of IVF/ICSI cycles, while
the option for SET instead of DET can lower pregnancy
and live birth rates [7]. The present meta-analysis aims to
compare current data on SET versus DET in fresh IVF/ICSI
cycles with respect to implantation, ongoing clinical preg-
nancy and live birth rates.
Methods
Criteria for considering studies for this meta-analysis
All published and ongoing randomized controlled trials
(RCT) compared current data on SET versus DET in fresh
IVF/ICSI cycles
Types of outcome measures
The outcome measures were implantation, ongoing clini-
cal pregnancy and live birth rates.
Identification of studies
Search strategies included online surveys of databases
(MEDLINE, EMBASE, Science Citation Index, Cochrane
Controlled Trials Register and OVID) from 1995 to 2008.
There was no language restriction. The following headings
and text strings were used: assisted reproductive technol-
ogy, multiple pregnancy, randomized controlled trial, sin-
gle-embryo transfer, and double-embryo transfer. The
principal inclusion criterion was randomized controlled
trial.
Validity assessment and data extraction
Each trial was assessed independently by two reviewers
and ranked for its methodological rigor and its potential
to introduce bias. Missing data were obtained from the
authors when possible.
Statistical analysis
Data management and analysis were conducted using the
StatsDirect statistical software (Cheshire, UK). The fixed-
effect model was used for odds ratio (OR). Fixed-effect
effectiveness was evaluated by the Mantel-Haenszel
method. A confidence interval for the Mantel-Haenszel
OR was calculated in the software StatsDirect using the
Robins, Breslow and Greenland variance formula. A chi-
square test statistic was used with its associated probabil-
ity that the pooled OR was equal to 1. The measure of het-
erogeneity (non-combinability) was evaluated by
Cochran's Q, the Breslow-Day and I2 tests. A non-signifi-
cant result (i.e. lack of heterogeneity) indicates that no
trial has an OR that is significantly worse or better than
the overall common OR obtained by pooling the data.
Since a fixed-effect model has been employed herein, it is
important to acknowledge that inferences refer only to the
particular studies included in the analysis. Meta-analysis
used in this manner is simply a device to pool the infor-
mation from the various studies to provide a composite
finding, but only for those studies.
Results
Search results
Seven trials fulfilled the inclusion criteria (Fig. 1).
Description of the studies included
Gerris et al. [2]
This study aimed to obtain comparative data on the pro-
spective implantation and pregnancy rates after SET and
DET. First, top quality embryo characteristics were deline-
ated by retrospectively analyzing embryos resulting in
ongoing twin pregnancies after DET. A top quality embryo
was characterized by the presence of 4 or 5 blastomeres atReproductive Biology and Endocrinology 2009, 7:36 http://www.rbej.com/content/7/1/36
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QUOROM statement flow diagram illustrating selection of trials included in the meta-analysis Figure 1
QUOROM statement flow diagram illustrating selection of trials included in the meta-analysis.
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day 2 and at least 7 blastomeres on day 3 after insemina-
tion, the absence of multinucleated blastomeres and
<20% cellular fragmentation on days 2 and 3 after fertili-
zation. Using these criteria, a prospective study was con-
ducted in women <34 years of age, who started their first
IVF/ICSI cycle. In order to be included in the randomiza-
tion, the patient had to agree to participate in the study
and she had to have at least two top quality embryos at the
time of embryo transfer. A total of 53 had produced at
least two top quality embryos and were prospectively ran-
domized. Randomization took place at the time of
embryo transfer using external concealment. In all, 26 SET
resulted in 17 conceptions (positive HCG), 14 clinical
(53.8%) and 10 ongoing pregnancies (38.5%) with one
monozygotic twin; 27 DET resulted in 22 conceptions; 21
clinical (77.8%) and 20 ongoing pregnancies (74%) with
six sets of (30%) twins.
Martikainen et al. [8]
This multicenter study aimed to compare the effectiveness
of SET and DET in a group of patients with good prog-
noses. An inclusion criterion in all four centers involved
was at least four good quality embryos. A good quality
embryo was defined as having symmetrical blastomeres
and <20% fragmentation on day 2. A total of 144 couples
agreed to participate in the study. They were randomized
into the SET or DET groups by means of a computer-gen-
erated random number table. The laboratory personnel
conducted the randomization just before embryo transfer
(ET). The implantation rates of the fresh embryos trans-
ferred were quite similar between the SET and the DET
groups (33.8% vs. 30.7%, respectively). The ongoing
pregnancy rates were slightly but not significantly higher
(29.7% vs. 40%) when two embryos were transferred.
Gardner et al. [9]
The objective of this study was to determine the efficacy of
single blastocyst transfer. Participation in this study was
offered to all patients undergoing IVF-ET with their own
oocytes during a 24-month period who met the criteria for
blastocyst stage ET. These criteria included a day-3 FSH =
10 mUI/ml, E2<80 pg/ml, normal endometrial cavity,
and at least 10 follicles >12 mm in diameter on the day of
HCG administration. Forty-eight patients were enrolled
after informed consent was obtained. Patients were rand-
omized at the time of transfer by a computer-generated
table into either SET or DET transfer on day 5. SET resulted
in an implantation and ongoing pregnancy rate of 60.9%,
with no twins. DET resulted in an implantation rate of
56%, an ongoing pregnancy rate of 76% with a 47.4%
incidence of twins.
Thurin et al. [10]
This study was designed to test the hypothesis that the rate
of pregnancies resulting in at least one live birth in
patients who had undergone the transfer of a single fresh
embryo and, if no live birth resulted, the subsequent
transfer of a frozen-and-thawed embryo, would be equiv-
alent to the rate in patients submitted to the simultaneous
transfer of two fresh embryos. Women were eligible for
randomization if they were <36 years of age at the time of
fresh ET, were undergoing their first or second in vitro fer-
tilization cycle, and had at least two embryos of good
quality available for transfer or freezing. Good-quality
embryos included embryos with less than 20% fragmen-
tation and 4 to 6 cells at day 2, 6 to 10 cells at day 3, or
expanded blastocysts at day 5 or 6. An embryologist with
the use of a computerized program performed randomi-
zation, at a ratio of 1:1, locally before the transfer, when
the embryos could be evaluated. A total of 661 patients
underwent randomization. Of those, 331 patients were
randomly assigned to undergo DET and 330 to undergo
SET. In fresh embryo transfer, the SET group had an ongo-
ing pregnancy rate (28.4%) statistically significantly lower
(P < 0.0001) than the DET group (44.1%). Also, the SET
group had a live birth rate (27.6%) statistically signifi-
cantly lower (P < 0.0001) than the DET group (42.9%)
Lukassen et al. [11]
Only patients undergoing their first IVF/ICSI cycle ever or
the first cycle after a successful treatment were included.
The age of the women had to be <35 years (at the time of
ET) with a basal FSH level <10 IU/l. At least two embryos,
with one excellent (grade 4) or one good (grade 3) quality
embryo, had to be available for transfer on day 3 after
oocyte retrieval: grade 4 = no blastomere fragmentation;
grade 3=<10% fragmentation. A total of 107 patients were
randomized into the SET (n = 54) or DET group (n = 53).
The primary outcome, the ongoing pregnancy rate, was
25.9% in the SET group and 35.8% in the DET group.
Van Montfoort et al. [12]
This study performed a randomized controlled trial (RCT)
to compare SET and DET in an unselected group of
patients (i.e. irrespective of the woman's age or embryo
quality). Patients who started their first IVF cycle were
assessed for eligibility to participate in the study. All had
to have normal fertilization of at least two oocytes (i.e. 2
PN embryos) in order to be randomly assigned to the SET
or DET group. A total of 308 patients was included: 154
patients for SET and for 154 DET. Randomization was
performed immediately prior to embryo transfer (using a
non-transparent box containing sealed opaque enve-
lopes). The clinical outcomes differed significantly
between the SET and DET groups, with the respective per-
centages of positive pregnancy tests after transfer of fresh
embryos being 33.1% versus 47.4%. The ongoing preg-
nancy rate after SET was significantly lower than in DET
(21.4 vs. 40.3%, respectively) and the twin PR was
reduced from 21.0% after DET to 0% after SET.Reproductive Biology and Endocrinology 2009, 7:36 http://www.rbej.com/content/7/1/36
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Moustafa et al. [13]
This study carried out a randomized controlled trial com-
paring SET versus DET in young women. Eighty-one
patients undergoing embryo transfer in the assisted repro-
duction unit were prospectively included. Inclusion crite-
ria were: women undergoing embryo transfer in a fresh
cycle, at least one good quality embryo on the day of
transfer, age ≤ 30 years at the time of embryo transfer, and
no contraindication for pregnancy. Randomization was
performed by a third party (a nurse) who was not
involved in any other aspect of the study. The results
showed that the live birth rate was not significantly differ-
ent between SET (30%) versus DET (31.7%).
Outcomes
Implantation rate (Fig 2)
Five studies were included [2,8-10,13]. The implantation
rate was not significantly different between DET group
(34.5%, 338/980) and SET group (34.7%, 163/470) (P =
0.96; OR = 0.99, 95% CI 0.78, 1.25). There was no heter-
ogeneity in this comparison (Breslow-Day = 1.33, df = 4,
P = 0.85; Cochran Q = 1.33, df = 4, P = 0.85; I2 = 0%, 95%
CI = 0% to 64.1%).
Ongoing clinical pregnancy rate (Fig. 3)
Six studies were included [2,8-12]. DET produced statisti-
cally significantly higher ongoing clinical pregnancy rate
(44.5%; 294/660) than SET (28.3%; 187/661) when
pooling results under the fixed-effect model (P < 0.0001;
OR: 2.06, 95% CI = 1.64 to 2.60). There was no heteroge-
neity in this comparison (Breslow-Day = 3.31, df = 5, P =
0.65; Cochran Q = 3.3, df = 5, P = 0.65; I2 = 0%, 95% CI =
0% to 61%).
Live birth rate (Fig. 4)
Five studies were included [2,8,10,11,13]. Pooled results
presented a significantly higher live birth rate when DET
(42.5%; 222/522) (P  < 0.001; OR: 1.87, 95% CI =
1.44,2.42) was compared with SET (28.4%; 149/524), a
comparison without heterogeneity (Breslow-Day = 4.0, df
= 4, P = 0.40; Cochran Q = 4.0, df = 4, P = 0.40; I2 = 0.4%,
95% CI = 0% to 64.2%).
Meta-analysis with 95% confidence showed that fresh
DET yielded a 1.64 to 2.60 times greater ongoing preg-
nancy rate and 1.44 to 2.42 times greater live birth rate
that SET in a population suitable for ART treatment.
Fixed-effect model Figure 2
Fixed-effect model. Implantation rates after single- and double-embryo transfer.Reproductive Biology and Endocrinology 2009, 7:36 http://www.rbej.com/content/7/1/36
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Fixed-effect model Figure 3
Fixed-effect model. Ongoing clinical pregnancy rates after single- and double-embryo transfer.
Fixed-effect model Figure 4
Fixed-effect model. Live birth rates after single- and double-embryo transfer.Reproductive Biology and Endocrinology 2009, 7:36 http://www.rbej.com/content/7/1/36
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Discussion
Although the risks should not be ignored, it appears exces-
sive to condemn twin pregnancies as necessarily constitut-
ing an adverse result and thus to impose rigorous limits
on DET utilization. In fact, the following factors that argue
in favor of the DET option should be considered:
Clinical pregnancy and live birth rates in a fresh IVF 
treatment cycle
SET in a fresh IVF treatment cycle reduces multiple births
but also lowers live birth and pregnancy rates in compar-
ison with double-embryo transfer. Van Montfoort et al.
[12] demonstrated that applying SET in the first cycle of
an unselected patient group would lead to a twin preg-
nancy rate of 0%. However, the price to be paid is a reduc-
tion of the ongoing pregnancy rate to approximately half
of that obtained after DET. Roberts et al. [14], using a sta-
tistical model of live birth and twin outcomes in terms of
routinely measured clinical parameters, demonstrated
that the live birth rate would be reduced by up to 20–30%
in order to achieve a 10% twin rate. Pandian et al. [7]
showed that SET in a fresh IVF/ICSI treatment cycle
reduces multiple births but also lowers pregnancy and live
birth rates in comparison with DET. Our meta-analysis,
which also showed statistically significantly higher ongo-
ing clinical pregnancy and live birth rates in DET, updates
the data with more recent studies and confirms this point.
Some authors [10,11,15] found that in a selected popula-
tion of women, transferring one fresh embryo and then, if
required, one or two frozen-thawed embryos significantly
reduces the twin pregnancy rate without decreasing the
overall pregnancy or live birth rate. However, the utility of
such approaches depends crucially on embryo culture,
selection and freezing policy [14]. Furthermore, this type
of analysis, which compares the result of 2 transfers (fresh
SET + frozen SET) with that of one transfer (fresh DET),
can be considered biased. Cryopreservation cycles can be
offered after DET as well, and the number of IVF/ICSI-SET
cycles needed to obtain pregnancy rates comparable with
DET cycles remains unknown [16]. On the other hand, if
published studies and editorial opinions are scrutinized,
their language usually refers to similar or acceptably high
pregnancy rates in carefully selected patients, but never
claims equivalency in pregnancy rates [17]
On the other hand, it was stated that we should be using
the available data not to argue against SET, but rather, to
find the optimal population of patients for whom it
would be beneficial. Three of the studies of our meta-anal-
ysis included women >35 years old in the SET group,
which may be considered inappropriate. However, when
we carried out the analysis considering only the studies
that included patients aged ≤ 35 years [2,10,11,13], the
results were equal to those of meta-analysis considering
all trials: Implantation rate: there was no significant differ-
ence between the DET group (33.8%, 267/790) and SET
group (33.2%, 124/373) (P = 0.90; OR = 1.02 (95% CI =
0.78, 1.33); Ongoing pregnancy rate: DET produced sta-
tistically significantly higher ongoing clinical pregnancy
rate (44.5%; 201/452) than SET (29.1%; 131/450) (P <
0.0001; OR:1.95, 95% CI = 1.48, 2.57) and Live birth rate:
pooled results presented a significantly higher live birth
rate when DET (42.9%; 194/452) (P < 0.0001; OR: 1.91,
95% CI = 1.45, 2.53) was compared with SET (28.2%;
127/450). Here also, as in the analysis considering all the
studies, there was no heterogeneity in any comparison.
Medical complications of a twin pregnancy
Twin pregnancies present substantial perinatal risks to
both the mother and the infants. However, due to
advances in health care, the maternal and perinatal risks
have decreased. Nine out of 10 children born after 32
weeks of gestation usually present a good prognosis with
a highly similar one-year survival rate between twins and
singletons [18]. In addition, Pinborg et al. [19] showed
that twins resultant from assisted reproduction present a
risk of neurological sequelae similar to that of twins natu-
rally conceived or even to singletons arising from assisted
reproduction. Van Wely [16] affirms that although multi-
ple gestations are associated with increased risk of compli-
cations for mothers and children, these complications
occur in few twin gestations, with the majority resulting in
the birth of two healthy babies. In addition, some authors
[20,21] observed better results with twin pregnancies after
assisted reproduction than those presented by spontane-
ously conceived twins.
On the other hand, Gleicher and Barad [22] reported that
most risk assessments in the literature are calculated with
pregnancy as the primary outcome, but in a fertility-treat-
ment paradigm where patients want more than one child
the statistically correct risk assessment should employ
childbirth as the primary reference. Thus, two separate
childbirths after SET (risks and complications) should be
compared with one twin live birth. In this manner, these
authors [22] showed that various twin pregnancy risks do
not exceed the relative risk of 2.0, representing the com-
bined risk of two singleton pregnancies required to
achieve the same outcome as one twin delivery (two chil-
dren). If we then further consider that IVF singleton preg-
nancies demonstrate higher adverse outcomes than
spontaneously conceived singletons [20], it is possible to
conclude that twin pregnancies (at least after IVF) do not
represent higher overall outcome risks per newborn than
singleton pregnancies [22].
Embryonic synergism in sustaining implantation
Two studies have reported applying the concept of embry-
onic synergy by creating mathematical models that pre-Reproductive Biology and Endocrinology 2009, 7:36 http://www.rbej.com/content/7/1/36
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dict the implantation potential and compare the
calculated results with the real results [23,24]. Both evi-
denced real multiple gestation (twin and triplets) rates
higher than the mathematically calculated ones and sug-
gested that this difference may reflect synergism of trans-
ferred embryos. Matorras et al. [24] estimated that the
implantation probability is increased by 22% for each
embryo additionally implanted. On the other hand, the
lower risk of spontaneous loss in multiple gestations evi-
denced in some studies also corroborates the embryonic
synergy concept. La Sala et al. [25] demonstrated that the
rate of spontaneous fetal loss among singletons was sig-
nificantly higher compared with losses among twins when
only top-quality embryos had been transferred. Glujovsky
et al.  [26] showed that twin pregnancies have a lower
chance of spontaneous embryo reduction than singletons.
Lambers et al. [27] also report lower total pregnancy loss
and loss per gestational sac in twin than in singleton ges-
tations. Probably, the embryonic synergy, besides improv-
ing the local environment for implantation, also can
promote a setting more favorable to pregnancy mainte-
nance and embryonic growth [26]. However, the embry-
Ideal flow chart for SET × DET comparison Figure 5
Ideal flow chart for SET × DET comparison.Reproductive Biology and Endocrinology 2009, 7:36 http://www.rbej.com/content/7/1/36
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onic synergy concept has been disputed [14]. In this meta-
analysis we did not observe any difference in the implan-
tation rates or even survival rates (after 12 weeks) per
embryo transfer for double- (29.9%) and single-embryo
(29.2%) transfer (P = 0.78).
Preference for a twin pregnancy in infertile patient
In the evaluation of twins, relevance applies not only to
medical outcomes but also to the opinion of couples who
have an unfulfilled wish for a child. For most couples who
desire to conceive, the ideal number of children is two
[28,29]. The largest preference study actually evaluated
the preference for a twin or singleton pregnancy of moth-
ers of IVF/ICSI twins (n = 266), IVF/ICSI singletons (n =
764) and mothers of spontaneous twins (n = 738) [30].
Mothers were approached with questionnaires at the time
their children were 3–4 years of age and were asked
whether they found either a singleton or twins more desir-
able as their first pregnancy. The study showed that 85%
of IVF/ICSI-twin mothers and 62% of IVF/ICSI-singleton
mothers would have preferred twins as their first delivery
outcome compared with 60% of the non-IVF/ICSI-twin
mothers. On the other hand, the couples apparently are
more inclined to accept a twin pregnancy when they are
not alerted to the risks [31]. However, this evidence is
questionable. Murray et al. [32] showed that couples do
not tend to take into account the risks associated with
twin births even after counseling. Women embarking on
IVF may be influenced more strongly by considerations of
'treatment success' rather than future risks to their off-
spring. Furthermore, their attitudes also seem to be more
affected by regulations governing the number of attempts
allowed, by the management of costs in the patients'
country and by their knowledge of the current results with
ART than by the possible risks [33].
In conclusion, DET poses diverse arguments in favor of its
use whereas the indiscriminate application of SET appears
unrealistic. SET represents an appropriate transfer option
for only a small minority of IVF patients if pregnancy rates
are to be satisfactory. The shift from DET to SET reduces
the risk of twin pregnancy with prejudice that is important
in pregnancy rates. Careful selection using couple charac-
teristics and, crucially, embryo quality markers has the
potential to mitigate the reduction in pregnancy rates in
SET [14]. Further evaluations including an appropriate
analysis of all short- and long-term results, all relevant
costs and their funding sources are necessary for compar-
ing the two embryo-transfer strategies (SET × DET). Figure
5 shows an ideal flow chart for SET versus DET compari-
son. It is only by a comprehensive approach that we will
be able to decide whether SET or DET should be preferred.
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